Cover Image
Market Research Report

Asia-Pacific Hemodynamic Monitoring Market - Segmented by System Type, by Application, by Product Type, and by Region - Growth, Trends, and Forecasts (2018 - 2023)

Published by Mordor Intelligence LLP Product code 708520
Published Content info 90 Pages
Delivery time: 1-2 business days
Back to Top
Asia-Pacific Hemodynamic Monitoring Market - Segmented by System Type, by Application, by Product Type, and by Region - Growth, Trends, and Forecasts (2018 - 2023)
Published: September 18, 2018 Content info: 90 Pages

Market overview:

The Asia-Pacific Hemodynamic Monitoring Market is expected to witness a robust growth due to the increase in the number of critically ill geriatric population, and a rise in the prevalence of cardiac disorders and diabetes. Hemodynamic monitoring devices are used to measure the blood pressure inside the veins, heart, and arteries. These devices are also used to monitor the blood flow and the concentration of oxygen in the blood.

Increase in the Number of Critically Ill Geriatric Population to Propel Growth of the Market

Increasing the critically ill geriatric population is one of the important drivers propelling the growth of the hemodynamic monitoring market. According to the economic and social commissions for Asia and Pacific, the number of people aged 65 or older is projected to grow from an estimated 16.8% of people out of the total population in 2016, to nearly 23.3% of the population by 2050, in the Asia-Pacific region. Age is associated with a progressive decline of the functional reserve of multiple organ systems. It is, therefore, not surprising that elderly patients may utilize a disproportionate share of healthcare resources, as approximately 92% of older adults have at least one chronic disease, and 77% have at least two. Increasing numbers of elderly patients (age >65 years) are being admitted to intensive care units (ICUs), with diagnosis ranging from exacerbations of chronic illnesses and new onset of catastrophic health problems to trauma caused by home-related incidents and injury-resultant accidents. The elderly population currently accounts for almost 50% of the ICU admissions. These patients require continuous monitoring of their vital parameters. Early and effective hemodynamic management with fluid therapy and administration of vasoactive drugs to maintain vital organ perfusion and oxygen delivery is mandatory in the critically ill patients. This is expected to increase the demand for hemodynamic monitoring, which in turn, may drive the Asia-Pacific hemodynamic monitoring market.

Rising Incidences of Complications Associated With Invasive Monitoring Systems to Restrain Growth of the Market

Some of the complications like bruising/bleeding at the site, hemorrhage, vascular erosion, infection, pneumothorax, and puncture or rupture of the pulmonary artery, among others, are associated with invasive monitoring systems. For instance, a pulmonary artery catheter is used for the measurement of hemodynamic variables, which cannot be done continuously by less invasive means. There are a number of complications associated with these systems. It can be either related to central venous access, insertion, and manipulation or due to the presence of the premature atrial contraction (PAC) in the cardiovascular system and errors resulting from incorrect interpretation. Furthermore, one of the most dangerous risks of this procedure is the pulmonary artery rupture, which has over 50% mortality rate. However, this is rare in patients over 60 years old who have pulmonary hypertension. Pediatric patients are more vulnerable to these complications. Therefore, extreme care is required while flushing lines, to avoid backward blood flow and fluid overload. Invasive hemodynamic monitoring is quite expensive and time-consuming, which may act as restraining factors for the global hemodynamic monitoring market. Other major complications associated with an invasive monitoring system are cardiac complications, perforation of heart or cava, rupture of the pulmonary artery, and hemoptysis. Hence, rising incidences of complications associated with invasive monitoring systems are major restraining factors for the growth of the market.

Japan Dominates the Asia-Pacific Hemodynamic Monitoring Market

Japan is currently one of the largest markets in the world for hemodynamic monitoring. It is estimated that there are approximately 680,000 high-risk surgical patients, per annum, in Japan. An Osaka City University study reported that hospitals belonging to the Japanese Society of Anesthesiologists (JSA) have a high rate of cardiac output (70%) and stroke volume variation (74%) monitoring. However, the implementation of fluid goal-directed therapy was poor (7.4%), with respect to high-risk surgeries. As per the study, approximately 47% of the JSA members were not consistent regarding CO optimization. Central venous pressure was used only in less than half of the cases. This demonstrates that despite the advancements in hemodynamic monitoring, cardiac output optimization is still implemented poorly in Japan. Japan has a lower number of intensive care units, as compared to the western countries. To improve the use of hemodynamic monitoring techniques, strong guidelines and protocols need to be implemented. Such guidelines could improve clinical outcomes and help anesthesiologists adopt perioperative cardiac output optimization universally, which is expected to drive the market studied over the forecast period.

Key Developments in the Asia-Pacific Hemodynamic Monitoring Market:

  • Jun 2018: LiDCO, the hemodynamic monitoring company, announces that it has been granted registration in Japan for its latest product, the LiDCOunity v2

Reasons to Purchase Asia-Pacific Hemodynamic Monitoring Market Report:

  • Analyzing various perspectives of the Asia-Pacific Hemodynamic Monitoring Market with the help of Porter's five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares and strategies employed by the major market players
  • 3-month analyst support along with the Market Estimate sheet (in Excel)

Customization of the Asia-Pacific Hemodynamic Monitoring Market Report:

This report can be customized to meet your requirements. Please connect with our representative who will ensure you get a report that suits your needs.

Table of Contents
Product Code: 50141

Table of Contents

1. Introduction

  • 1.1. Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1. Current Market Scenario
  • 5.2. Porter's Five Forces Analysis
    • 5.2.1. Bargaining Power of Suppliers
    • 5.2.2. Bargaining Power of Consumers
    • 5.2.3. Threat of New Entrants
    • 5.2.4. Threat of Substitute Product and Services
    • 5.2.5. Competitive Rivalry Within the Industry

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

  • 6.1. Market Drivers
    • 6.1.1. Increase in the Number of Critically Ill Geriatric Population
    • 6.1.2. Rise in the Prevalence of Cardiac Disorders and Diabetes
  • 6.2. Market Restraints
    • 6.2.1. Increased Incidences of Complications Associated with Invasive Monitoring Systems
    • 6.2.2. Precision of Co-determinations Adversely Affected Under Low Flow Conditions
  • 6.3. Opportunities
  • 6.4. Key Challenges

7. Market Segmentation

  • 7.1. By System Type
    • 7.1.1. Minimally Invasive Monitoring Systems
    • 7.1.2. Invasive Monitoring Systems
    • 7.1.3. Non-invasive Monitoring Systems
  • 7.2. By Application
    • 7.2.1. Laboratory-based Monitoring Systems
    • 7.2.2. Home-based Monitoring Systems
    • 7.2.3. Hospital-based Monitoring Systems
  • 7.3. By Product Type
    • 7.3.1. Cardiac Output Monitors
    • 7.3.2. Catheters
    • 7.3.3. Connecting Tubes
    • 7.3.4. Guidewires
    • 7.3.5. IV Fluids
    • 7.3.6. Transducers
    • 7.3.7. Others
  • 7.4. By Region
    • 7.4.1. Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of APAC

8. Company Profiles & Competitive Landscape

  • 8.1. Edwards Life Sciences Corporation
  • 8.2. LiDCO Group PLC.
  • 8.3. ICU Medical Inc.
  • 8.4. Schwarzer Cardiotek Gmbh
  • 8.5. Philips Healthcare
  • 8.6. Cheetah Medical Inc.
  • 8.7. Getinge Group
  • 8.8. GE Healthcare
  • 8.9. Draeger Medical

List Not Exhaustive

9. Future of the Market

Back to Top